Research and Markets has announced the addition of the "Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.
The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019
The microfluidic device market is categorized on the basis of material used for manufacturing microfluidic devices, industry, application and geography. Based on industry, the microfluidic device market comprises in-vitro diagnostics, pharmaceuticals and medical devices. The application market comprises point of care testing, analytical devices, pharmaceutical and life science research, clinical and veterinary diagnostics, drug delivery and environment and industry.
Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as healthcare at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare.
Additionally, the microfluidic technique has evolved into a new classification of research areas, targeting integration of laboratory protocols into miniaturized devices called lab on chip. Microfluidic devices offer various advantages for genomics including improved test speed, reduced reagent consumption and efficacy.
North America has the largest share in the global microfluidic device market. In-vitro diagnostics is the largest industry, and clinical and veterinary diagnostics is the largest application of microfluidic device market. In terms of growth, Asia is the fastest growing region, medical devices are the fastest growing industry and point of care testing is the fastest growing application of microfluidic devices.
North America was valued at USD 644.5 million in 2013 and is expected to reach USD 2,095.5 million in 2019, growing at a CAGR of 21.7% from 2013 to 2019. In-vitro diagnostics microfluidic device market was valued at USD 949.6 million in 2013 and is expected to reach USD 3,317.4 million in 2019, growing at a CAGR of 23.2% from 2013 to 2019.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Industry Analysis
Chapter 4 Market Trends
Chapter 5 Porters Five Force Analysis
Chapter 6 Global Market Size and Forecast
Chapter 7 Segment Analysis - by Material
Chapter 8 Segment Analysis - by Industry
Chapter 9 Segment Analysis - by Application
Chapter 10 Regional Analysis
Chapter 11 Competitive Landscape
Chapter 12 Company Profiles
- Abbott Laboratories
- Agilent Technologies Inc
- Becton, Dickinson and Company
- Bio- Rad Laboratories
- Dolomite Centre
- Fluidigm Corporation
- Johnson & Johnson
- Micronit Microfluidics
- RainDance Technologies
- Roche Diagnostics
- Siemens Healthcare
For more information visit http://www.researchandmarkets.com/research/mhtj8b/microfluidic